0% commission for ETF tradesBioShares Biotechnology Clinical Trials ETF Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
A buy signal generated when short-term moving averages cross long-term moving averages in an upward direction.
Sell Signal (MA)
A sell signal generated when short-term moving averages cross long-term moving averages in a downward direction.
AI Analysis of BBC
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
BioShares Biotechnology Clinical Trials ETF upgraded from Buy Candidate to Strong Buy Candidate after Thursday trading session
(Updated on Sep 19, 2024)
Buy or Hold candidate since Sep 06, 2024
Gain 11.88%
The BioShares Biotechnology Clinical Trials ETF price gained 3.34% on the last trading day (Thursday, 19th Sep 2024), rising from $28.61 to $29.57. During the last trading day the ETF fluctuated 2.74% from a day low at $29.17 to a day high of $29.97. The price has risen in 6 of the last 10 days and is up by 8.51% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 thousand more shares were traded than the day before. In total, 2 thousand shares were bought and sold for approximately $69.58 thousand.
The ETF lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 7.24% during the next 3 months and, with a 90% probability hold a price between $28.59 and $34.14 at the end of this 3-month period.
BBC Signals & Forecast
The BioShares Biotechnology Clinical Trials ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $28.49 and $27.34. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, August 08, 2024, and so far it has risen 15.19%. Further rise is indicated until a new top pivot has been found. BioShares Biotechnology Clinical Trials has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The ETF had a Golden Star Signal on Monday, June 03, 2024 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Golden Star 12 Months
The ETF had a Golden Star Signal on Monday, June 03, 2024 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Support, Risk & Stop-loss for BioShares Biotechnology Clinical Trials ETF
On the downside, the ETF finds support just below today's level from accumulated volume at $26.09 and $25.39. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, BioShares Biotechnology Clinical Trials finds support just below today's level at $26.09. If this is broken, then the next support from accumulated volume will be at $25.39 and $24.75.
This ETF is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the ETF moved $0.800 (2.74%) between high and low. For the last week, the ETF has had daily average volatility of 1.56%.
Our recommended stop-loss: $28.48 (-3.68%) (This ETF has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 38 days ago.)
Trading Expectations (BBC) For The Upcoming Trading Day Of Friday 20th
For the upcoming trading day on Friday, 20th we expect BioShares Biotechnology Clinical Trials Fund to open at $29.57, and during the day (based on 14 day Average True Range), to move between $28.96 and $30.18, which gives a possible trading interval of +/-$0.611 (+/-2.07%) up or down from last closing price. If BioShares Biotechnology Clinical Trials Fund takes out the full calculated possible swing range there will be an estimated 4.13% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $29.74 (0.56%) than the support at $26.09 (11.79%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is BioShares Biotechnology Clinical Trials Fund ETF A Buy?
BioShares Biotechnology Clinical Trials holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
5.383
Strong Buy Candidate
Upgraded
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on September 20, 2024 - $29.57 ( 0.0002%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for BBC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 30.37 | 2.71% |
| R2 | 30.06 | 1.67% |
| R1 | 29.88 | 1.03% |
| Price | 29.57 | |
| S1 | 29.26 | -1.03% |
| S2 | 29.08 | -1.67% |
| S3 | 28.77 | -2.71% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 30.27 | 2.37% |
| R1 | 29.74 | 0.558% |
| Price | 29.57 | |
| S1 | 26.09 | -11.79% |
| S2 | 25.39 | -14.14% |
| S3 | 24.75 | -16.31% |
BBC Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 20, 2023 | Dec 20, 2023 | Dec 20, 2023 | $0.0820 | 0.369% |
| 2 | Dec 19, 2017 | Dec 20, 2017 | Dec 27, 2017 | $0.297 | 1.04% |
| 3 | Dec 21, 2015 | Dec 21, 2015 | Dec 29, 2015 | $0.147 | 0.498% |
FAQ
Click here for our free guide on how to buy BioShares Biotechnology Clinical Trials Fund ETF.
